Menu
Clinical Injection
Joint / Sub-Q / IV Delivery
Joint / Sub-Q / IV Delivery Day Surgery / Outpatient

Plantar Fascia Injection (Steroid)

Protocol / Details

Identify the point of maximal tenderness at the medial calcaneal tubercle. Position the patient prone with the foot hanging off the edge of the table. Prepare the site with aseptic technique using povidone-iodine or chlorhexidine. Utilize a 25-gauge needle to inject a mixture of 1-2 ml of local anesthetic (e.g., 1% lidocaine) and a corticosteroid (e.g., triamcinolone or methylprednisolone). Direct the needle medially at a 90-degree angle to the skin toward the attachment of the plantar fascia. Inject the medication slowly, avoiding intratendinous injection, to ensure a peri-fascial depot.

Procedure Type
Injection / Infusion
Estimated Base Cost
Varies by patient
Medical & Surgical Disclaimer The clinical information provided regarding this procedure is for educational purposes only. Only a qualified specialist or surgeon can determine if you are a suitable candidate for this intervention after a thorough examination.

Review medical history to exclude contraindications such as active local infection, systemic coagulopathy, or allergy to injectants. Perform physical examination to localize the site of maximal tenderness. Obtain informed consent and ensure baseline vital signs are stable.

Advise the patient to avoid strenuous activity or impact exercise for 48 hours. Use of ice packs for 15 minutes every few hours for local soreness is recommended. Monitor for signs of infection or post-injection flare. Patient is discharged immediately after observation.

Comprehensive Clinical Guide: Plantar Fascia Steroid Injection

1. Introduction and Overview

Plantar fasciitis is one of the most common causes of heel pain in clinical practice, affecting approximately 10% of the population over their lifetime. When conservative measures—such as orthotics, physical therapy, NSAIDs, and stretching protocols—fail to resolve symptoms after 3 to 6 months, clinicians often turn to corticosteroid injections as a second-line, minimally invasive intervention.

A plantar fascia steroid injection involves the localized delivery of a potent anti-inflammatory agent (typically a synthetic corticosteroid mixed with a local anesthetic) directly into the peritendinous space of the plantar fascia. The goal is to provide rapid relief of inflammation and pain, allowing the patient to return to functional activity and continue rehabilitation. This guide provides an exhaustive clinical overview for medical professionals and patients seeking a deep understanding of this procedure.


2. Deep-Dive: Mechanisms of Action

The therapeutic efficacy of a corticosteroid injection in the treatment of plantar fasciitis is rooted in its potent anti-inflammatory and immunosuppressive properties.

  • Pharmacodynamics: Corticosteroids (e.g., Triamcinolone, Betamethasone, or Dexamethasone) act by binding to glucocorticoid receptors in the cytoplasm. This complex translocates to the nucleus, where it alters gene expression, leading to:
    • Inhibition of Phospholipase A2: This reduces the release of arachidonic acid, thereby blocking the synthesis of prostaglandins and leukotrienes.
    • Reduction of Capillary Permeability: This decreases local edema and exudation at the insertion site.
    • Suppression of Fibroblast Proliferation: While this helps reduce chronic inflammation, it is also the mechanism responsible for the rare but serious risk of tissue atrophy.
  • The "Cocktail" Effect: Typically, a short-acting local anesthetic (e.g., Lidocaine) is mixed with the steroid. This provides immediate diagnostic confirmation (if the pain vanishes instantly, the source is confirmed) and provides transient relief until the steroid’s anti-inflammatory effect peaks, usually within 48 to 72 hours.

3. Clinical Indications & Patient Selection

Not every patient with heel pain is a candidate for steroid injection. Proper patient selection is critical to avoiding complications.

Indications

  • Chronic Plantar Fasciitis: Pain lasting >3–6 months despite conservative therapy.
  • Failure of First-Line Treatment: Patient has exhausted options including NSAIDs, night splints, physical therapy, and custom orthotics.
  • Diagnostic Confirmation: Used to differentiate between plantar fasciitis and other conditions like tarsal tunnel syndrome or calcaneal stress fractures.

Contraindications

Category Contraindication
Infection Local cellulitis or systemic infection.
Integrity History of plantar fascia rupture or high risk of imminent rupture.
Allergy Known hypersensitivity to corticosteroids or local anesthetics.
Systemic Uncontrolled diabetes (risk of glycemic spike) or coagulopathy.
Anatomical Severe atrophy of the heel fat pad.

4. Patient Pre-Operative Preparation

Preparation focuses on clinical assessment and risk mitigation.

  1. Clinical Assessment: Confirm the diagnosis via palpation (maximal tenderness at the medial calcaneal tubercle) and imaging (ultrasound to confirm thickening of the fascia, typically >4mm).
  2. Informed Consent: The patient must be explicitly informed of the risk of fat pad atrophy, plantar fascia rupture, and potential skin depigmentation.
  3. Anticoagulation Review: While rarely contraindicated, patients on blood thinners should be evaluated for potential hematoma risks, though the procedure is minimally invasive.
  4. Site Preparation: Strict aseptic technique is mandatory. The skin should be cleaned with povidone-iodine or chlorhexidine.

5. The Procedure: Step-by-Step

The procedure is generally performed in an outpatient clinic setting.

Step 1: Positioning
The patient is placed in a prone or supine position with the foot accessible. If supine, the knee is flexed with the foot resting on the table.

Step 2: Landmark Identification
The clinician identifies the maximal point of tenderness—usually the medial aspect of the calcaneal tuberosity.

Step 3: Anesthesia
A small amount of 1% lidocaine is injected subcutaneously at the entry point to minimize discomfort during the primary injection.

Step 4: Needle Insertion
Using a 22- to 25-gauge needle, the clinician advances toward the plantar fascia. Ultrasound guidance is highly recommended to ensure the needle enters the peritendinous space rather than injecting directly into the fascia (which increases rupture risk) or the subcutaneous fat pad.

Step 5: Injection
Once the needle is positioned, the clinician performs a gentle aspiration to ensure no blood return. The steroid-anesthetic mix is injected slowly. The fluid should flow with low resistance. If resistance is high, the needle is likely embedded in the fascia itself; it should be retracted slightly.


6. Post-Operative Recovery Protocol

The "Golden Rule" post-injection is relative rest.

  • Immediate (0–24 hours): Apply ice to the heel for 15 minutes every 2 hours to minimize post-injection flare. Avoid weight-bearing as much as possible for the first 24 hours.
  • Short-Term (1–7 days): Transition to normal activities, but avoid high-impact sports (running, jumping).
  • Rehabilitation: Resume physical therapy exercises, specifically calf stretches and plantar fascia-specific stretching, as the pain relief allows for better compliance.
  • Follow-up: Re-evaluation at 4–6 weeks to determine if a second injection is necessary (though most guidelines advise a maximum of 3 injections per year to avoid tissue degradation).

7. Risks and Complications

While highly effective, the procedure is not without risks:

  1. Plantar Fascia Rupture: The most feared complication. Usually occurs due to direct intratendinous injection or exceeding the recommended number of injections.
  2. Fat Pad Atrophy: Steroids can cause the protective subcutaneous fat layer of the heel to shrink, leading to permanent pain during walking.
  3. Post-Injection Flare: A transient increase in pain occurring within 24–48 hours due to the crystallization of the steroid.
  4. Infection: Rare, but serious (septic arthritis or deep tissue infection).
  5. Skin Hypopigmentation: Localized lightening of the skin at the injection site.

8. Alternative Treatments

If the steroid injection fails, clinicians should consider:

  • Platelet-Rich Plasma (PRP) Therapy: Uses the patient's own growth factors to stimulate healing rather than just suppressing inflammation.
  • Extracorporeal Shockwave Therapy (ESWT): Uses acoustic waves to stimulate micro-trauma and promote natural healing in chronic tissues.
  • Tenex/Micro-tenotomy: A minimally invasive procedure to remove scarred, necrotic tissue from the fascia.
  • Surgical Plantar Fasciotomy: A last-resort option involving the release of the fascia, typically reserved for cases that have failed all other interventions for 12+ months.

9. Frequently Asked Questions (FAQ)

1. How long does the pain relief last?
Results vary, but many patients experience relief for 3 to 6 months. It is not a permanent cure but a bridge to allow for healing.

2. Is the injection painful?
There is moderate discomfort during the procedure. However, the use of a local anesthetic and a small-gauge needle makes it manageable for most patients.

3. How many injections can I have?
Most orthopedic guidelines recommend no more than three injections in a 12-month period to minimize the risk of fascia rupture and fat pad atrophy.

4. Can I walk immediately after the injection?
You can walk, but it is highly recommended to limit weight-bearing activity for the first 24 hours to ensure the steroid stays in the target area.

5. What is "post-injection flare"?
This is a temporary increase in pain that happens as the steroid begins to work. It usually subsides within 48 hours and is managed with ice and NSAIDs.

6. Does it work better with ultrasound guidance?
Yes. Studies show that ultrasound-guided injections are more accurate, provide better long-term pain relief, and carry a lower risk of injecting into the fat pad or directly into the fascia.

7. Will this cure my plantar fasciitis?
The injection addresses the inflammation, but it does not fix the underlying biomechanical issues. You must continue physical therapy and orthotic use to address the root cause.

8. What if I am a diabetic?
Steroids can cause temporary blood sugar spikes. Diabetics should monitor their glucose levels closely for 48 hours post-injection and consult their primary physician.

9. Can I drive home after the procedure?
Yes, most patients can drive, though you may feel some numbness in the heel for a few hours due to the anesthetic.

10. What are the signs of a serious complication?
If you experience intense, worsening pain after 48 hours, fever, chills, or visible redness and warmth spreading from the site, contact your physician immediately, as these may indicate an infection.


10. Summary Table: Clinical Outlook

Feature Details
Typical Success Rate 70–85% for short-term relief.
Onset of Relief 2–5 days post-procedure.
Common Steroid Triamcinolone (Kenalog) or Betamethasone.
Primary Risk Plantar fascia rupture / Fat pad atrophy.
Ideal Candidate Chronic patient with failed conservative care.

Disclaimer: This guide is for educational purposes for medical professionals and patients. It does not replace the professional judgment of a healthcare provider. Always consult with an orthopedic specialist to determine the appropriate treatment plan for your specific clinical presentation.

Share this procedure: